Skip to main content
logo
Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.4300
+0.0100 (2.38%)
At close: Oct 14, 2026

Avenue Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1242619
Market Cap Growth
-37.33%-47.28%92.60%-61.53%-70.79%-80.95%
Enterprise Value
-1-311518
Last Close Price
0.430.682.0012.0887.001021.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1.54----
PB Ratio
2.491.182.213.261.705.50
P/TBV Ratio
2.491.181.471.351.425.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-3.41-1.56-1.40-2.73-2.05-1.09
Asset Turnover
-0.50----
Quick Ratio
1.382.603.181.491.877.57
Current Ratio
1.402.673.281.551.917.78
Return on Equity (ROE)
-164.83%-159.82%-931.95%-535.10%-107.28%-128.43%
Return on Assets (ROA)
-63.14%-73.31%-311.89%-209.03%-93.05%-64.85%
Return on Capital Employed (ROCE)
-544.80%-179.40%-607.90%-2223.20%-246.30%-108.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-196.00%-134.34%-283.65%-486.53%-64.07%-19.66%
Buyback Yield / Dilution
-34.27%-141.75%-817.14%-384.72%-92.83%-2.98%